The successful integration of oral oncolytics into practice depends on collaboration of the multidisciplinary cancer care team to guide patients through treatment with optimal medical, financial, and psychosocial support. CANCER BUZZ spoke to Dr. Mazyar Shadman, MD, MPH, Associate Professor of Clinical Research at Fred Hutch in Seattle, WA. Hear as our expert describes process improvement strategies to successfully integrate oral oncolytics into practice, and highlights how patient goals can be included in treatment planning.

Mazyar Shadman, MD, MPH

Associate Professor – Clinical Research Division - Fred Hutch

Associate Professor - Medical Oncology Division- University of Washington

Attending Physician – Seattle Cancer Care Alliance

Seattle, WA

Resources:

• Blog: Integrating Oral Oncolytics into Chronic Lymphocytic Leukemia Practice
• Integrating Oral Oncolytics into Chronic Lymphocytic Leukemia (CLL) Practice
• The Role of Pharmacy to Help Manage Patients with Cancer on Oral Oncolytics